# A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA

> **NCT00006430** · PHASE1 · UNKNOWN · sponsor: **National Center for Research Resources (NCRR)**

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** Autologous dendritic cells transfected with amplified tumor RNA

## Key facts

- **NCT ID:** NCT00006430
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006430, "A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*